Clinical pharmacist performance in a hospital in times of COVID-19: experience report
DOI:
https://doi.org/10.33448/rsd-v11i9.31740Keywords:
Drug-related problem; Clinic pharmacy; Medication review; COVID-19; Health teaching.Abstract
The clinical pharmacy is concerned with solving and avoiding drug-related problems. The clinical pharmacist works focused on the pharmacotherapy and clinical condition of the assisted person; its work is also carried out in multidisciplinary cooperation, embracing the integrality of the SUS. This article focuses on the report of the experiences lived by a clinical pharmacist in the surgical clinic of a teaching hospital from September 2020 to February 2021, in times of COVID-19. As for the method, it is an experience report of the activities developed by the professional and supervised by the preceptor clinical pharmacist. The discussions were guided based on what was experienced in the clinic, being arranged in guiding axes of discussion, addressing topics relevant to the professional performance of the pharmacist. This professional proved to be crucial in times of the COVID-19 pandemic, in education, medication review, monitoring of adverse reactions and laboratory tests, and in providing medication-related guidance and recommendations. Therefore, it was possible to highlight the importance of the clinical pharmacist in the competence of integrality, this has relevance in public health, being crucial in the times of the COVID-19 pandemic, based on health education and the rational use of medicines.
References
Agência Nacional de Vigilância Sanitária (ANVISA). Resolução RDC nº 63, de 25 de novembro de 2011. Dispõe sobre os Requisitos de Boas Práticas de Funcionamento para os Serviços de Saúde. Brasil.
American College of Clinical Pharmacy. Lenexa: About Clinical Pharmacists; 2014. http://www.accp.com/about/clinicalpharmacists.aspx.
Cardinal L, Fernandes C. (2013). Intervenção farmacêutica no processo da validação da prescrição médica. Rev. Bras. Farm. Hosp. Serv. Saúde, 5(2), 14-19. https://www.santapaula.com.br/Arquivos/IEP_farmacia_trabalho021.pdf
Carneiro, F. S., Bezerra, A. L. Q., Silva, A. E. B. C., Souza, L. P., Paranaguá, T. T. B., & Branquinho, N. C. S. S. (2011). Eventos adversos na clínica cirúrgica de um hospital universitário: instrumento de avaliação da qualidade. Rev. Enferm. Uerj,19(2), 204-211. https://repositorio.bc.ufg.br/bitstream/ri/15685/5/Artigo%20-%20Fernanda%20Salerno%20Carneiro%20-%202011.pdf
Comitê de consenso. (2007). Terceiro Consenso de Granada sobre Problemas Relacionados com Medicamentos (PRM) e Resultados Negativos associados a Medicação (RNM). Ars Pharmaceutica Granada, 48(1), 5-17. https://adm.online.unip.br/img_ead_dp/35344.PDF
Conselho Federal de Farmácia. RDC n° 585, de 29 de agosto de 2013. Regulamenta as atribuições clínicas do farmacêutico e dá outras providências. Diário Oficial da União.
David, M. T. S. S. (2021). O impacto do uso indiscriminado de antibióticos na pandemia COVID-19. In: V.R.S., Marques, A.E.B., Duarte, J.D., Munhoz (organizadores). Pandemia: caminhos para aprendizagem. (1a. ed., Cap. 11, pp. 165-174). São Carlos: Pedro & João editores.
Duarte, H. A., Freire J. C. G., & Silva L. M. (2015). A estruturação de uma visita multiprofissional para o acompanhamento integral de idosos: relato da experiência em um hospital universitário. In: 4º congresso internacional de envelhecimento humano. Campina Grande. Paraiba, CIEH, 1-6. https://editorarealize.com.br/artigo/visualizar/11931
Elbeddini, A., Prabaharan, T., Almasalkhi, S., & Tran, C. (2020) Pharmacists and COVID-19. Journal Of Pharmaceutical Policy And Practice,36(13), 1-4. https://doi.org/10.1186/s40545-020-00241-3
Erstad, B. L. (2020). Caring for the COVID Patient: A Clinical Pharmacist’s Perspective. Annals of Pharmacotherapy, 55(3), 413-414. 10.1177/1060028020954224
Hendricks, S., LaMothe, V. J., Kara, A., & Miller, J. (2017) Facilitators and Barriers for Interprofessional Rounding: a Qualitative Study. Clin. Nurse Spec., 31(4), 219-228. 10.1097/NUR.0000000000000310.
Hepler, C. D., & Strand, L. M. (1990). Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm, 47(3), 533-543. https://pubmed.ncbi.nlm.nih.gov/2316538/
Kral, E. E., & Coulson, L. A. (2020) The Clinical Pharmacist’s Role in Perioperative Surgical Pain Management. Journal Of Pain & Palliative Care Pharmacotherapy, 34(3),120-126. 10.1080/15360288.2020.1734141
Kwan, Y., Fernandes, O. A., Nagge, J. J., Wong, G. G., Huh, J., Hurn, D. A. & Bajcar, J. M. (2007). Pharmacist Medication Assessments in a Surgical Preadmission Clinic. Arch Intern Med, 167(10), 1034-40. 10.1001/archinte.167.10.1034
Lei 8080, de 19 de setembro de 1990. Dispõe sobre as condições para a promoção, proteção e recuperação da saúde, a organização e o funcionamento dos serviços correspondentes e dá outras providências. Brasília, DF.
Mansoor, L. E., & Dowse, R. (2006). Medicines information and adherence in HIV/AIDS patients. Journal of Clinical Pharmacy and Therapeutics, 31(1), 7-15. 10.1111/j.1365-2710.2006.00696.x
Marwitz, K. K. (2021). The pharmacist’s active role in combating COVID-19 medication misinformation. Journal of the American Pharmacists Association, 61(2), e71-e74. 10.1016/j.japh.2020.10.022
Menezes, K. B., Silva, A. S., Cunha-Mattos, C. E., Nutels, T., Oliveira, D. A., Neves, S. J. & Gonçalves, M. G. L. (2021). Association between drug discrepancies and length of stay in the surgical clinic at a university hospital. Rev Bras Farm Hosp Serv Saude, 12(2), 1-5. 10.30968/rbfhss.2021.122.0547
Meng, L., Huang, J., Qiu, F., & Sun, S. (2020). Roles of the Chinese clinical pharmacist during the COVID-19 pandemic. J Am Coll Clin Pharm, 10.1002/jac5.1274. 10.1002/jac5.1274
Oliboni, L. S., & Camargo, A. L. (2009). Validação da prescrição oncológica: o papel do farmacêutico na prevenção de erros de medicação. Rev HCPA, 29(2),147-152. https://seer.ufrgs.br/index.php/hcpa/article/view/7474/5815
Queiroz, M. J. (2009). SOAP Revisitado. Rev Port Clin Geral, 25(1), 221-227. https://doi.org/10.32385/rpmgf.v25i2.10610
Salviano, A. F., Diniz, A. G., Santiago, L. B., Souza, P. P., Girão, R. P., & Rego, T. J. R. (2017). Atuação interdisciplinar em um serviço hospitalar de urgência e emergência pediátrica. Esperança. João Pessoa, 15(2), 27-33. http://www.facene.com.br/wp-content/uploads/2010/11/4-ATUA%C3%87%C3%83O-INTERDISCIPLINAR-EM-UM-SERVI%C3%87O-HOSPITALAR-DE-URG%C3%8ANCIA-E-EMERG%C3%8ANIA-PEDI%C3%81TRICA.pdf
Saseen JJ, Ripley T, Bondi D, Burke, J. M., Cohen, L. J., McBane, S. & Griend, V. J. P. (2017) ACCP Clinical Pharmacist Competencies. Pharmacotherapy, 37(5), 630-636. 10.1002/phar.1923
Silva, N. R. R., Leopardi-Gonçalves, M. G., Oliveira, A. V. B., & Tomaz, A. C. (2022). Relevância do farmacêutico na prática clínica hospitalar. Research, Society and Development, 11(7), 1-7. http://dx.doi.org/10.33448/rsd-v11i7.29992
Siqueira, L. F., Gomes, N. L. C., & Gonçalves, K. A. M. (2021) Atuação do farmacêutico clínico no âmbito hospitalar. Brazilian Journal of Health Review. Curitiba, 4(6), 25467-25485. https://doi.org/10.34119/bjhrv4n6-149
Souza, A. A. P., Biazon, A. C. B., & Aran, T. P. S. (2021). Avaliação de problemas relacionados a medicamentos em pacientes polimedicados. Infarma, 33(e1), 67-74. https://revistas.cff.org.br/?journal=infarma&page=article&op=view&path%5B%5D=2758
Tuna, J. M. F. (2015) Problemas relacionados com o uso do medicamento e o impacto das intervenções farmacêuticas no âmbito hospitalar. (dissertação de mestrado). Universidade de Coimbra, Coimbra, Portugal. 228p.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Ana Valéria Bígio de Oliveira; Neyva Roberta Ribeiro da Silva; Ozileudiane Barros Santos da Silva; Fabian Menezes de Souza Câmara; Antonio Thomás da Silva; Maria das Graças Leopardi-Gonçalves
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
